Iovance Biotherapeutics, Inc.IOVANASDAQ
Loading
PB Ratio: Discounted ValuationCompressed
Percentile Rank14
3Y CAGR-11.8%
5Y CAGR-32.2%
Year-over-Year Change
Price-to-book ratio
3Y CAGR
-11.8%/yr
vs +2.5%/yr prior
5Y CAGR
-32.2%/yr
Recent acceleration
Acceleration
-14.3pp
Decelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
2 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 1.40 | -53.8% |
| 2024 | 3.02 | -7.7% |
| 2023 | 3.27 | +60.5% |
| 2022 | 2.04 | -56.8% |
| 2021 | 4.71 | -51.8% |
| 2020 | 9.77 | -15.1% |
| 2019 | 11.51 | +523.4% |
| 2018 | 1.85 | -48.5% |
| 2017 | 3.59 | +55.9% |
| 2016 | 2.30 | - |